Screening for strongyloides infection among the institutionalized mentally disabled

Journal of the American Board of Family Practice

Volumn 14, Issue 1, 2001, Pages 51-53

  Nair, Dilip ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; TIABENDAZOLE;

ARTICLE; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INSTITUTIONALIZATION; MALE; MASS SCREENING; MENTAL PATIENT; MIDDLE AGED; NEMATODIASIS; ORGANIZATION AND MANAGEMENT; UNITED STATES;

ANTHELMINTICS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INSTITUTIONALIZATION; MALE; MASS SCREENING; MENTALLY DISABLED PERSONS; MIDDLE AGED; STRONGYLIDA INFECTIONS; THIABENDAZOLE; WEST VIRGINIA;

EID: 0035229215     PISSN: 08938652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Atchley FO. Clinical note: survey of enteric parasites in population of eastern Kentucky. J Parasitol 1959; 45:518.
2. Fulmer HS, Huempfner HR. Intestinal helminths in eastern Kentucky: a survey in three rural counties. Am J Trop Med Hyg 1965;14:269-75.
3. Walzer PD, Milder JE, Banwell JG, Kilgore G, Klein M, Parker R. Epidemiologic features of Strongyloides stercoralis infection in an endemic area of the United States. Am J Trop Med Hyg 1982;31:313-9.
4. Proctor EM, Muth HA, Proudfoot DL, et al. Endemic institutional strongyloidiasis in British Columbia. CMAJ 1987;136:1173-6.
5. Braun TI, Fekete T, Lynch A. Strongyloidiasis in an institution for mentally retarded adults. Arch Intern Med 1988;148:634-6.
6. Schupf N, Ortiz M, Kapell D, Kiely M, Rudelli RD. Prevalence of intestinal parasite infections among individuals with mental retardation in New York State. Ment Retard 1995;33:84-9.
7. MacLean JD, Libman M. Screening returning travelers. Infect Dis Clin North Am 1998;12.-431-43.
8. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis 1989;11:755-67.
9. Milder JE, Walzer PD, Kilgore G, Rutherford I, Klein M. Clinical features of Strongyloides stercoralis in an endemic area of the United States. Gastroenterology 1981;80:1481-8.
10. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 1981;3:397-407.
11. Morgan JS, Schaffner W, Stone WJ. Opportunistic strongyloidiasis in renal transplant recipients. Transplantation 1986;42:518-24.
12. Davidson RA, Fletcher RH, Chapman LE. Risk factors for strongyloidiasis. A case-control study. Arch Intern Med 1984;144:321-4.
13. Sato Y, Kobayashi J, Toma H, Shiroma Y. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg 1995;53:248-50.
14. Kawatu D, Lees RE, Maclachlan RA. Screening for intestinal parasites. Is a single specimen valid? Can Fam Physician 1993;39:1748-50.
15. Genta RM. Predictive value of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of strongyloidiasis. Am J Clin Pathol 1988;89:391-4.